Drug Master Files for: ENZALUTAMIDE
✉ Email this page to a colleague
ENZALUTAMIDE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
29062 | A | II | 3/23/2015 | SAI LIFE SCIENCES LTD | 4-((2-CYANOPROPAN-2-YL)AMINO)-2-FLUORO-N-METHYLBENZAMIDE (ENZALUTAMIDE INTERMEDIATE) |
29117 | A | II | 3/31/2015 | DR REDDYS LABORATORIES LTD | ENZALUTAMIDE |
29872 | A | II | 5/24/2016 | TEVA PHARMACEUTICAL INDUSTRIES LTD | ENZALUTAMIDE |
30010 | A | II | 11/28/2015 | MYLAN LABORATORIES LTD | ENZALUTAMIDE |
30260 | A | II | 3/17/2016 | SHILPA MEDICARE LTD | ENZALUTAMIDE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information